Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
Department of Epidemiology, and the Department of Biostatics, School of Public Health, University of North Carolina at Chapel Hill, EE.UU.
New England Journal of Medicine, 342(11):790-790
Lectura recomendada:
[Intravenous Clodronate in the Treatment of Reflex Sympathetic Dystrophy Syndrome. A Randomized, Double Blind, Placebo Controlled Study]
Journal of Rheumatology, 27:1483-1483
Lectura recomendada:
[Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain]
Pain, 86:119-132
Lectura recomendada:
[Prevalence of Rheumatic Manifestations and Antineutrophil Cytoplasmic Antibodies in Haematological Malignancies. A Prospective Study]
Rheumatology (Oxford), 39(4):420-420
Lectura recomendada:
[Primary Prevention of Glucocorticoid-Induced Osteoporosis with Intravenous Pamidronate an Calcium: A Prospective Controlled 1-Year Study Comparing a Single Infusion, an Infusion Given Once Every 3 Months, and Calcium Alone]
Journal of Bone and Mineral Research, 16(1):112-112
Lectura recomendada:
[Long-Term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial]
The Lancet , 357(9252):251-256
Lectura recomendada:
[Long-Term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial]
The Lancet , 357(9252):251-256
Lectura recomendada:
[Chiropractic Care for Patients Aged 55 Years and Older: Report from a Practice-Based Research Program]
Journal of the American Geriatrics Society, 48:534-545
Lectura recomendada:
[A cognitive-behavioral group intervention as prevention for persistente neck and back pain in a non-patient population: a randomized controlled trial]
Pain, 90:83-90
Lectura recomendada:
[Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial]
The Lancet , 357:251-256